Literature DB >> 7086355

Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein.

F C de Beer, A K Soutar, M L Baltz, I M Trayner, A Feinstein, M B Pepys.   

Abstract

C-reactive protein (CRP), the classical acute-phase protein, can bind phospholipids by virtue of its specific, calcium-dependent reactivity with phosphorylcholine residues. However, analysis of acute-phase serum by gel filtration and by density gradient ultracentrifugation showed that the CRP was in a free, uncomplexed form, despite the coexistent presence of the various classes of serum lipoproteins, all of which contain phospholipids. In contrast, when isolated CRP was aggregated by immobilization at a sufficient density on a solid phase and then exposed to normal human serum, it selectively bound low density lipoprotein (LDL) and traces of very low density lipoprotein. The reaction was calcium dependent and reversible by free phosphorylcholine but not by heparin. LDL isolated from normal plasma was also bound by aggregated CRP. CRP reacts in vitro with a wide variety of different ligands both of extrinsic and of autogenous origin, e.g., microbial products and damaged cell membranes, respectively. If CRP aggregated in vivo by complexing with these ligands than acquires the capacity to selectively bind LDL, the phenomenon may have significant implications for the function of CRP and for the metabolism, clearance, and deposition of LDL.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7086355      PMCID: PMC2186728          DOI: 10.1084/jem.156.1.230

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  40 in total

1.  Interactions of C-reactive protein with the first component of human complement.

Authors:  D R Claus; J Siegel; K Petras; A P Osmand; H Gewurz
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

Review 2.  Lipoprotein metabolism.

Authors:  S Eisenberg; R I Levy
Journal:  Adv Lipid Res       Date:  1975

3.  Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins).

Authors:  A P Osmand; B Friedenson; H Gewurz; R H Painter; T Hofmann; E Shelton
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

4.  A simple method for the isolation of the subcomponents of the first component of complement by affinity chromatography.

Authors:  S N Assimeh; D H Bing; R H Painter
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Limulin: a C-reactive protein from Limulus polyphemus.

Authors:  F A Robey; T Y Liu
Journal:  J Biol Chem       Date:  1981-01-25       Impact factor: 5.157

7.  Estimation of the molecular size of C-reactive protein and CX-reactive protein in serum.

Authors:  I Kushner; J A Somerville
Journal:  Biochim Biophys Acta       Date:  1970-04-28

Review 8.  Binding of C-reactive protein to C-carbohydrate and PC-substituted protein.

Authors:  E C Gotschlich; T Y Liu; E Oliveira
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

9.  THE OCCURRENCE DURING ACUTE INFECTIONS OF A PROTEIN NOT NORMALLY PRESENT IN THE BLOOD : IV. CRYSTALLIZATION OF THE C-REACTIVE PROTEIN.

Authors:  M McCarty
Journal:  J Exp Med       Date:  1947-04-30       Impact factor: 14.307

10.  Studies of acute phase protein. I. An immunohistochemical method for the localization of Cx-reactive protein in rabbits. Association with necrosis in local inflammatory lesions.

Authors:  I KUSHNER; M H KAPLAN
Journal:  J Exp Med       Date:  1961-12-01       Impact factor: 14.307

View more
  66 in total

Review 1.  C-reactive protein: a critical update.

Authors:  Mark B Pepys; Gideon M Hirschfield
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

2.  Oxidized phosphatidylcholines: pattern recognition ligands for multiple pathways of the innate immune response.

Authors:  Stanley L Hazen; Guy M Chisolm
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

3.  Membrane curvature recognition by C-reactive protein using lipoprotein mimics.

Authors:  Min S Wang; Reid E Messersmith; Scott M Reed
Journal:  Soft Matter       Date:  2012-08-14       Impact factor: 3.679

4.  C-reactive protein and atherogenesis: new insights from established animal models.

Authors:  Jan Torzewski
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

Review 5.  Statins, inflammation and kidney disease.

Authors:  Vera Krane; Christoph Wanner
Journal:  Nat Rev Nephrol       Date:  2011-05-31       Impact factor: 28.314

Review 6.  The role of C-reactive protein as a risk predictor of coronary atherosclerosis: implications from the JUPITER trial.

Authors:  Thura T Abd; Danny J Eapen; Ambareesh Bajpai; Abhinav Goyal; Allen Dollar; Laurence Sperling
Journal:  Curr Atheroscler Rep       Date:  2011-04       Impact factor: 5.113

7.  C-reactive protein exists in an NaCl concentration-dependent pentamer-decamer equilibrium in physiological buffer.

Authors:  Azubuike I Okemefuna; Lasse Stach; Sudeep Rana; Akim J Ziai Buetas; Jayesh Gor; Stephen J Perkins
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

8.  C-reactive protein and apoB containing lipoproteins are associated with Mycobacterium leprae in lesions of human leprosy.

Authors:  M J Ridley; D S Ridley; F C De Beer; M B Pepys
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

9.  Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein.

Authors:  Sanna Taskinen; Petri T Kovanen; Hanna Jarva; Seppo Meri; Markku O Pentikäinen
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

Review 10.  The connection between C-reactive protein and atherosclerosis.

Authors:  Sanjay K Singh; Madathilparambil V Suresh; Bhavya Voleti; Alok Agrawal
Journal:  Ann Med       Date:  2008       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.